Recruiting

Genetic Testing

Sponsor:

University of Illinois at Chicago

Code:

NCT07145138

Conditions

Heart Failure

Dilated Cardiomyopathy (DCM)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Study Details

Brief summary:

Dilated cardiomyopathy (DCM), a condition where the heart loses its ability to pump blood throughout the body, is a common cause of death in the United States (US). It affects minorities more frequently and appears to causes greater harm than Whites. However, almost all research related to DCM has been performed in Whites, where up to half of cases run in the family. Several genes have been identified that cause the disease, but we are unsure if these same genes are also responsible for DCM in African Americans or Hispanic/Latino patients. The impact of various medical, social, and financial stressors on the severity of the disease in ethnic minorities also remains unclear. The investigators believe that certain genes are more common in different racial and ethnic groups and the greater medical, social, and financial burden faced by minorities in the US leads to more harm from DCM in these groups. The overall goal of the project is to test whether ethnic minority patients carrying genes that cause DCM experience more adverse effects in part because of various medical, social, and financial burdens. The investigators will first establish the UIC Multi-ethnic DCM Biorepository to look for how often certain genes are found across different race-ethnicity and then ask the question if these genes impact the severity of DCM. Finally, the investigators will study how a person's environment can alter the course of their disease. Through this, the investigators hope and strive to ensure equal and adequate heart care for individuals regardless of their race-ethnicity.

Conditions

Heart Failure

Dilated Cardiomyopathy (DCM)

Study ID

NCT07145138

Start date

Jul 11, 2024

Status verified date

Aug, 2025

Completion date

Dec 31, 2038

Anticipated

Primary completion date

Dec 31, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Must be at least 18 years of age and be admitted to or seen at a UIH site.
  • Subjects must be willing and able to give written, informed consent

Exclusion Criteria:

  • Adults who are unable to provide consent
  • Women who are pregnant at the baseline visit,
  • Prisoners
  • Individuals who are not yet adults (infants, children, teenagers).

Study Design

Enrollment

1500 participants

Anticipated

Interventions and Outcome Measures

Arms

Dilated Cardiomyopathy

Control

Primary outcome measure

  • Likely Pathogenic/Pathogenic Variants [ Time Frame: Baseline ]

Central Contacts and Locations

Central contacts

David Tofovic, M.D.

312-355-7111dtofov2@uic.edu

Locations

University of Illinois Hospital & Health Sciences

Recruiting

Chicago, Illinois, United States, 60612

Contacts

More Information

Sponsor

University of Illinois at Chicago

Last update posted

Aug 28, 2025

Last verified

Aug, 2025

Keywords

  • Dilated Cardiomyopathy
  • Heart Failure
  • Genomics
  • Social Determinants of Health
  • Variant

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Illinois at Chicago on 2025-08-28.